The Human Genetics Research Group at the University of Tartu Faculty of Medicine has identified a rare variant in the MGRN1 gene that may cause congenital heart malformations in fetuses. This discovery is particularly significant because MGRN1 has not previously been associated with early human development or any disease. The identification of this genetic defect will help doctors better recognize similar cases in the future and improve both counseling and treatment offered to affected families. The finding represents a breakthrough in understanding the genetic causes of fetal cardiac defects.
Discovery of MGRN1 Gene Variant and Its Link to Heart Malformations
- ▪The MGRN1 gene has not previously been associated with early human development
- ▪The Human Genetics Research Group of the University of Tartu Faculty of Medicine identified a gene whose defect may cause congenital heart malformations in the fetus
Clinical Implications for Diagnosis and Family Counseling
- ▪The University of Tartu discovery of the MGRN1 gene defect will help doctors better recognize similar cases in the future
- ▪The University of Tartu discovery of the MGRN1 gene defect will improve the counseling offered to affected families
Perspective of University of Tartu researchers
- ▪The MGRN1 gene discovery will enable more accurate genetic diagnosis of fetal heart defects in clinical settings
- ▪The identification of the MGRN1 gene variant represents a breakthrough in understanding the genetic causes of congenital heart malformations
Perspective of Affected families and expectant parents
- ▪Parents carrying MGRN1 gene variants may gain better understanding of recurrence risks in future pregnancies
- ▪Families with fetuses diagnosed with congenital heart malformations may receive more precise genetic explanations through MGRN1 testing
Story comments
Loading comments…